baber/WOPTO huggingface dataset:
Patent DE-69026992-T2 (DE)
Inventor: TAKABAYASHI HIROSHI
IPC: H05K3/32
Filed: 1990-08-16
Granted: 1996-10-24
Abstract: Electrode terminals formed on a pair of a circuit substrate and another circuit substrate or electrical element are mutually connected electrically by the medium of electroconductive particles. Prior to the connection, the electroconductive particles (4) may be charged and dispersed onto a circuit substrate (11) to be selectively attached to the electrode terminals (8) thereon. The selective attachment may be enhanced by masking a part other than the connecting part of the electrode terminals (8) of the circuit substrate with an insulating member or film (10) so as to guide the charged electroconductive particles (7) along electric lines of force directed to the exposed parts of the electrode terminals. The attached electroconductive particles (9) are sandwiched between the pair of circuit substrates, which may be secured to each other by means of an insulating adhesive or an electroconductive resin.
Patent DE-69028560-T2 (DE)
Inventor: YAMAMOTO YOHZOH
IPC: C08J5/18
Filed: 1990-02-20
Granted: 1997-03-06
Abstract: A sheet or a film is disclosed formed of at least one cyclo-olefin polymer selected from ring-opened polymers derived from at least one cyclo-olefin of formula (I) <CHEM> wherein n is 0 or a positive integer, and each of R<1> to R<1><2> independently represents hydrogen, a halogen or an aliphatic, aromatic or alicyclic hydrocarbon group; two of R<9> to R<1><2> form, together with the carbon atoms to which they are bonded, a monocyclic or polycyclic group which may contain a double bond; or R<9> and R<1><0>, or R<1><1> and R<1><2> form an alkylidene group together with the carbon atoms to which they are bonded; ring-opened copolymers derived from the cyclo-olefins of formula (I), hydrogenation products of said polymers or copolymers and addition polymers of the cyclo-olefins of formula (I) with ethylene, said cyclo-olefin polymer having an intrinsic viscosity [ eta ], measured in decalin at 135 DEG C, of 0.01 to 10 dl/g and a softening temperature of at least 70 DEG C. Sheets and films of the invention have good properties of elongation resistance, ease of tearing and chemical resistance as well as providing an effective gas barrier
Patent DE-69032048-T2 (DE)
Inventor: MALMGREN KENT
IPC: A61L15/16
Filed: 1990-11-07
Granted: 1998-08-06
Abstract: A fat-cleaving lipase is used for the enzymatic degradation of resin in chemithermomechanical fluff-pulp (CTMP-fluff) by hydrolysis of the triglycerides present in the resin to fatty acids readily washable from the pulp, with the intention of improving the liquid absorbency of the fluff pulp when forming from said pulp such sanitary articles as soft paper, disposable diapers or the like. The lipase is supplied either:  - to wet CTMP-pulp or to chips intended for a CTMP-process.s
Patent DE-69102357-T2 (DE)
Inventor: THOMPSON PETER
IPC: F04D29/16
Filed: 1991-06-24
Granted: 1995-01-19
Abstract: A multi-stage centrifugal pump with an axially split casing (10) and a number of impellers (14) carried by a drive shaft (12) has inter-stage bushings (24) and rings (22) for sealing each side of each impeller. Each bushing (24) or ring (22) is conventionally prevented from rotating by a radial pin protruding from the lower half of the casing (10) into an axial slot in the periphery of the bushing or ring. The pin is necessarily small and is liable to shear, difficult to engage in the slot and, in cases where the bushing (24) or ring (22) is diametrically split, does not allow rotation of the lower half for its removal without lifting the shaft (12). To avoid all these disadvantages, the exposed end (37) of a tangential pin (32) fitted in the casing (10) is flush with the join face (28) of the casing and abuts against a shoulder (44) formed by a recess (38) in the periphery of the bushing (24) or ring (22). This pin (32) can be larger than the known radial pin and is subjected to compression, not shear. <IMAGE>
Patent DE-69103538-T2 (DE)
Inventor: BATISTA MARLI F
IPC: A61K9/40
Filed: 1991-01-21
Granted: 1994-12-22
Abstract: A simulated capsule-like medicament comprising a dual subcoating comprising an initial subcoating of a water soluble film forming polymer, e.g. povidone and a secondary subcoating of a mixture of two soluble film forming polymers, e.g. povidone and hydroxypropyl methylcellulose and a hydrophobic plasticizer, e.g. castor oil, which provides for a smooth uniform and substantially bubble free outer coating, e.g. gelatin, for the capsule-like medicament; and a process of making such medicaments.
Patent DE-69122331-T2 (DE)
Inventor: CHARMOT DOMINIQUE
IPC: C08F12/00
Filed: 1991-07-19
Granted: 1997-04-30
Abstract: The dispersions are prepared by aqueous emulsion polymerisation of ethylenically unsaturated monomers containing at least 60 % of styrene and/or butadiene and/or acrylic ester and/or vinyl nitrile in the presence of a chain transfer agent chosen from diphenyl disulphides substituted by an alkoxy, alkyloxy or acylamino radical. 
<??>The dispersions obtained have the advantage of exhibiting a low odour level.
Patent DE-69123220-T2 (DE)
Inventor: MISAWA RINTARO
IPC: A61G3/00
Filed: 1991-08-02
Granted: 1997-03-13
Abstract: A stair-climbing wheelcarrier comprises a carrier portion comprising a pair of endless belt crawlers and a handle rotatably mounted on the carrier portion. A guide body is provided to mount a wheelchair and secured to the handle so as to be pivoted together with the handle. An electric screw jack is provided between the carrier portion and the guide body for holding the guide body at a desired position. <IMAGE>
Patent DE-69124041-T2 (DE)
Inventor: OHTSUBO KAZUO
IPC: H01L35/00
Filed: 1991-09-18
Granted: 1997-05-28
Abstract: There is disclosed a noise-reducing element (1) with at least one junction (4, 5, 6) between component (2, 3) of different kinds of electroconductive materials. The electrodes are constituted by a part of at least of the components. Further, the thermoelectric power of the respective materials in the element exceeds + or - 50  mu VK<-1> at the temperature of the element under the state in which the noise-reducing element is activated. Also, there is rectifying action to a harmless extent at the junction. <IMAGE>
Patent DE-69131017-T2 (DE)
Inventor: HUSE WILLIAM
IPC: C07K19/00
Filed: 1991-12-20
Granted: 1999-07-15
Abstract: The invention relates to methods for manipulating nucleic acids so as to optimize the binding characteristics of an encoded binding protein by providing two or more nucleic acids encoding binding proteins having at least one set of splicing sites, the set of splicing sites flanking opposite ends of one or more encoded binding domains; mixing the nucleic acids to produce a parent population of mixed nucleic acids encoding binding proteins; and randomly incorporating the binding domains between the nucleic acids through the set of splicing sites to produce a different population of nucleic acids encoding binding proteins wherein at least one binding protein is characterized by substantially different binding characteristics than a member of the parent population.
Patent DE-69133096-T2 (DE)
Inventor: ADAMS CARL A
IPC: G07F7/08
Filed: 1991-10-25
Granted: 2003-04-17
Abstract: In a transaction approval system (10) in which a transaction limit (30) and a list (42) of the card account numbers of invalid transaction cards are stored in a terminal (16) the terminal (16) also generates and stores lists (44,46) of account numbers which might be invalid and should provoke an on-line request for authorisation. One (44) of the lists generated is of card account numbers where the transaction exceeded the transactions limit (30) and was refused by the central processor (12). The other list (46) generated is of card account numbers where the transaction was approved off-line, so that the next transaction by a card holder whose number is on this list (46) will be automatically referred for on-line approval. <IMAGE>
Patent DE-69202891-T2 (DE)
Inventor: DUBIEF CLAUDE
IPC: A61K8/04
Filed: 1992-03-11
Granted: 1995-11-23
Abstract: The invention relates to the use of lactoferrin for preserving the mechanical properties of hair, and in particular its tensile strength and its elasticity, from degradation by atmospheric aggression, and in particular by light. The lactoferrin is used for this purpose in an amount of between 0.05 and 5% by weight, in a cosmetically acceptable carrier, and preferably in the form of a combination with 8-hydroxyxanthine and 2-thioxanthine, in proportions of 0.2 to 2% of lactoferrin, 0.01 to 0.1% of 8-hydroxyxanthine and 0.01 to 0.3% of 2-thioxanthine, optionally combined with 0.01 to 5% of an enzyme superoxide dismutase.
Patent DE-69209851-T2 (DE)
Inventor: GUSTAFSON AKE
IPC: E05B39/02
Filed: 1992-12-07
Granted: 1996-09-05
Abstract: A safety sealing device includes a support. An electronic safety circuit is glued to one face of the support. The electronic safety circuit includes a winding of fine wire connected to an electronic component. The electronic component is activated and interrogated by outside checking means via the winding, which acts as an antenna. The electronic component may be coded so that it responds to the interrogation with its code. The safety sealing device may further comprise differentiated gluing means. When attempting to tamper with the support to which the safety circuit has been glued in order to unseal a receiving article, the attempt at ungluing or a tearing causes a break in the continuity of the electronic circuit. As a result, the electronic component no longer responds to an interrogation with its code, thus assuredly indicating that the safety sealing device has been tampered with.
Patent DE-69210667-T2 (DE)
Inventor: DEMARS YVES
IPC: E04F13/08
Filed: 1992-03-19
Granted: 1996-12-19
Abstract: System for connecting panels 1, 4, 5, 30, 31 of a facade of the ''structural glazing'' type and the structure of the building which supports the weight of all the panels and allows a bottoming (oscillation) in the directions perpendicular to the facade. The connection between the system and a panel preferably takes place by way of a circular hole in the latter by means of off-centre circular rings 15, 16. <IMAGE>
Patent DE-69213949-T2 (DE)
Inventor: MORROW FLOYD L
IPC: B60P3/34
Filed: 1992-06-03
Granted: 1997-03-06
Abstract: A unit is described comprising a towable wheeled undercarriage upon which is mounted a unit having four independent rooms, each of which is collapsed for towing and which can be greatly extended in volume both horizontally and vertically for use. The four rooms have a common corner at the center of the unit. Each room includes a slide out section slidable beyond the sides of the undercarriage and an inner section that is attached to the floor. The slide out sections can be extended simultaneously until their roofs lock to a main roof over the fixed inner room sections. All roofs and their attached, telescoped, upper room walls can be raised simultaneously by a single drive device, such as a hydraulic cylinder, at the center of the main roof at the common corner of the rooms. With the rooms extended and the vertically extending rooms telescoped up, four large, private, independent, solid-walled, rooms with separate exterior doors are created. The undercarriage is mounted on four wheels on two axles. The forward axle is longer than the rear axle, so that the wheels can be nested together to provide improved stability and ease of towing.
Patent DE-69216600-T2 (DE)
Inventor: HALE GEOFFREY
IPC: A61P35/00
Filed: 1992-04-16
Granted: 1997-07-03
Abstract: PCT No. PCT/GB92/00705 Sec. 371 Date Oct. 15, 1993 Sec. 102(e) Date Oct. 15, 1993 PCT Filed Apr. 16, 1992 PCT Pub. No. WO92/18530 PCT Pub. Date Oct. 29, 1992.A synthetic antigen having the amino acid sequence Gly-Gln-Asn-Asp-Thr-Ser-Gln-Thr-Ser-Ser-Pro-X wherein X is Ser, Ser-Ala, Ser-Ala-Ser, Ser-Ala-Ser-Ser, Ser-Ala-Ser-Ser-Asn, Ser-Ala-Ser-Ser-Asn-Ile, Ser-Ala-Ser-Ser-Asn-Ile-Ser, or an antigenic fragment thereof, a process of the production of the antigen and the use of the antigen in assaying for purifying or inducing CDw52 antibody.
Patent DE-69216994-T2 (DE)
Inventor: BAVAY JEAN-CLAUDE
IPC: C21D8/12
Filed: 1992-10-26
Granted: 1997-06-12
Abstract: Process for manufacturing a magnetic steel strip which has a thickness of less than 5 mm and contains, in composition by weight, more than 2 % of silicon, less than 0.1 % of carbon and elements which inhibit secondary recrystallisation in an appropriate quantity, the remainder being iron, obtained by direct casting on a cylinder or between two cylinders, which process is characterised in that a crystallisation structure is created, comprising {110} <001> oriented grains as a skin, that is to say at the surface of the quenching zone, due to the abrupt cooling of the steel in contact with the roll(s), the surface temperature of which is lower than 400 DEG C. <IMAGE>
Patent DE-69217760-T2 (DE)
Inventor: KOMODA MOTOYOSHI
IPC: H04W24/06
Filed: 1992-05-20
Granted: 1997-06-12
Abstract: The present invention relates to a self-diagnosing method which shortens the diagnosing time for a ROM which is provided within a mobile telephone set for use in a mobile telephone switching system and mobile telephone set being applied the method. When the power supply is turned ON, a complementary value which complements to set up the sum of data stored within all the addresses of the ROM as a certain specific value, ROMCHK, which is the content of the data stored within a specific address of the ROM, is compared with NVMCHK which is the content of data stored previously within a specific address of a non-volatile memory with the same value as the ROMCHK. If they do not coincide, then the content of the data within the entire area of the ROM is calculated for the diagnosis. In this case, the content stored within the specific address of the ROM is the sum of the data values within the entire area of the ROM, and the content stored within the specific address of the non-volatile memory is the same as this sum value. <IMAGE>
Patent DE-69222221-T2 (DE)
Inventor: PATSIDIS KONSTANTINOS
IPC: C08F10/00
Filed: 1992-05-08
Granted: 1998-01-15
Abstract: Processes are disclosed for preparing compounds of the formula Z-R-Z where each Z can be selected from cyclopentadienyl type radicals such as substituted or unsubstituted cyclopentadienyl, indenyl, fluorenyl or tetrahydroindenyl or where one Z is Cl, Br, or I by reacting specific Z precursors with a dihaloalkylene compound. Also new cyclopentadienyl-type compounds are disclosed.
Patent DE-69222705-T2 (DE)
Inventor: KOMODA MOTOYOSHI
IPC: G06F11/00
Filed: 1992-07-17
Granted: 1998-03-26
Abstract: A system for detecting the malfunction of a CPU (Central Processing Unit) is disclosed. A watchdog timer applies an interrupt signal to the CPU on detecting the malfunction of the CPU. In response to the interrupt signal, the CPU executes interrupt processing to increment the number of times that the CPU has malfunctioned stored in a nonvolatile memory. As the number of times stored in the nonvolatile memory reaches a predetermined value, the CPU displays an alarm message on a display. <IMAGE>
Patent DE-69227823-T2 (DE)
Inventor: OSBORN THOMAS
IPC: A61F5/44
Filed: 1992-07-23
Granted: 1999-05-12
Abstract: A napkin comprises an absorbent core between a pervious topsheet and an impervious backsheet, with all parts extensible, and a fastener for securing the napkin to the garment, the fastener allowing at least parts of the napkin to extend. The napkin is pref. extensible both longitudinally and transversely and may require extending before applying to the garment, or may be extended by forces applied during use. Stretched length is pref. at least 25% greater than unstretched length. The napkin may be provided with a pull-out tab so that the user can lengthen the napkin.
Patent DE-69228944-T2 (DE)
Inventor: BABIUK LORNE
IPC: A61K39/00
Filed: 1992-12-11
Granted: 1999-12-02
Abstract: Recombinant subunit vaccines against bovine herpesvirus type 1 (BHV-1) are provided, as well as methods of vaccination and methods of recombinantly producing the subunit antigens or nucleotide sequences employed in the vaccines. Preferably, the subunit is a truncated BHV-1 gIV antigen.
Patent DE-69302587-T2 (DE)
Inventor: LYRMALM EBBE
IPC: C09J103/02
Filed: 1993-06-17
Granted: 1996-10-02
Abstract: PCT No. PCT/SE93/00541 Sec. 371 Date Jan. 6, 1995 Sec. 102(e) Date Jan. 6, 1995 PCT Filed Jun. 17, 1993 PCT Pub. No. WO94/01619 PCT Pub. Date Jan. 20, 1994The present invention provides a paper sizing composition which comprises a sizing agent selected from cyclic dicarboxylic acid anhydride or alkyl ketene dimer, a stabilizing and/or dispersing agent which is an amphoteric polymer and a polyaluminum compound.
Patent DE-69304065-T2 (DE)
Inventor: SKIBA MOHAMED
IPC: A61J3/07
Filed: 1993-06-16
Granted: 1997-03-20
Abstract: PCT No. PCT/FR93/00594 Sec. 371 Date Mar. 8, 1995 Sec. 102(e) Date Mar. 8, 1995 PCT Filed Jun. 16, 1993 PCT Pub. No. WO93/25195 PCT Pub. Date Dec. 23, 1993A nanoparticulate system prepared by: 1) preparing a liquid phase essentially consisting of a solution of cyclodextrin modified by acyl groups in an organic solvent or solvent mixture, an active molecule being optionally added thereto; 2) preparing a second liquid phase essentially consisting of water or an aqueous mixture optionally containing one or more surfactants, and optionally having an active molecule added thereto; and 3) gently stirring one of the liquid phases resulting from 1) or 2) into the other in order to obtain, almost instantaneously, a colloidal solution of modified cyclodextrin nanospheres. If required, all or part of the solvent and all or part of the water may be removed. The system may be used as a carrier for pharmaceuticals, cosmetics, chemicals, etc.
Patent DE-69304995-T2 (DE)
Inventor: MOSSER VINCENT
IPC: H01L43/06
Filed: 1993-05-18
Granted: 1997-02-06
Abstract: Hall-effect sensor of the type with two-dimensional electron gas and comprising, on an insulating substrate (10), a quantum well structure (12), a carrier-yielding layer (20) adjacent to the quantum well structure (12), less than 250 angstroms thick and having a surface density of donors, when integrated through the whole thickness of the carrier-yielding layer, of less than 5 10<12>cm<-2>, an insulating disposal layer (22) deposited on the carrier-yielding layer, having a conduction band of energy greater than the Fermi energy of the sensor and greater than 200 angstroms thick. Application to the field of electrical counters and current sensors. <IMAGE>
Patent DE-69311712-T2 (DE)
Inventor: LI CHIEN-WEI
IPC: C04B35/584
Filed: 1993-04-08
Granted: 1997-10-30
Abstract: A silicon nitride sintered body has a composition consisting essentially of 85 to 94 % by weight  beta  silicon nitride, 6 to 15 % by weight grain boundary phase consisting essentially of (i) at least two rare earth elements, wherein yttrium is considered a rare earth, and, optionally, strontium which, calculated as SrO, is 0 to 2 percent by weight of the total body, and (ii) at least two of Si, N, O and C, and an additive consisting essentially of a metal carbon compound present in the amount of about 0.2 to 3.5 % by volume. The additive is substantially homogeneously dispersed within the sintered body. The sintered body has a microstructure wherein (i) the  beta silicon nitride grains are acicular and have an average grain width ranging from 0.5 to 1.5  mu m, (ii) at least 25 % of the grains have width greater than 0.7  mu m, and at least 10 % of the grains have width greater than 1  mu m, and (iii) no more than 5 % of grains have width greater than 3.5  mu m and apparent aspect ratio greater than 5, with the proviso that the average aspect ratio is at least 1.8 and a fracture origin, at least 90 % of which is comprised of large acicular  beta Si3N4 grains, the average size of which ranges from about 15 to 50  mu m. Such a ceramic has high strength, high toughness and long term durability, and is especially suited for industrial applications such as components for gas turbine and automotive engines.
Patent DE-69321846-T2 (DE)
Inventor: BORDERS RICHARD
IPC: A47C19/02
Filed: 1993-12-06
Granted: 1999-03-18
Abstract: A bed, in particular a hospital bed, comprises a bed frame structure, said bed frame structure being provided with a head side end portion thereof and a foot side end portion thereof, said end portions each comprising a laterally extending end bar (44, 50), each of said end bars (44, 50) being provided for carrying a substantially U-shaped bar (52) and for carrying a panel (54) extending within an area surrounded by said U-shaped bar (52) and said end bar (50), each of said end bars (44, 50) being provided with at least two insert holes (102, 104), having a tapered longitudinal section profile with a taper angle for receiving correspondingly tapered insertion pins (106, 108) being provided on said panel (54), said taper angle being dimensioned so as to enable attachment and detachment of said panel (54) to and from said end bar (50) with said U-shaped bar (52) being carried by said end bar (50). <IMAGE>
Patent DE-69327620-T2 (DE)
Inventor: FERNANDEZ ORDONEZ ALICIA
IPC: C07K16/28
Filed: 1993-08-18
Granted: 2000-08-03
Abstract: A monoclonal antibody which recognizes human Epidermal Growth Factor (EGF) receptor, is capable of inhibiting EGF binding to the receptor, is capable of inhibiting growth of EGF-dependent tumor cells, and in addition has at least one of the following properties:     a) has antibody-dependent cellular cytotoxicity,   b) has complement-mediated cytotoxic activity, c) is capable of producing a synergetic effect in inhibiting proliferation of tumor cells if combined with a ganglioside, d) is capable of producing a synergetic effect in inhibiting proliferation of tumor cells if combined with a monoclonal antibody against EGF, or a derivative of said monoclonal antibody selected from humanized, chimeric, reshaped, bispecific, conjugated and anti-idiotypic forms of it, or a fragment of said monoclonal antibody or said derivative selected from Fv, Fab, Fab' and F(ab')2 fragments of it. A composition comprising said monoclonal antibody, in particular a pharmaceutical composition for use in a therapeutical or prophylactic treatment of malignant neoplasms or pre-neoplastic diseases. A process for preparing the monoclonal antibody, use of it and an immortalized cell producing it.
Patent DE-69331574-T2 (DE)
Inventor: BEARDSLEY TERRY R
IPC: A61K35/26
Filed: 1993-03-09
Granted: 2002-10-02
Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a thymus-derived factor which stimulates, enhances or regulates cell-mediated immune responsiveness. In one embodiment, the factor is a substantially homogeneous immune potentiator which stimulates mature T lymphocytes and thus enhances the response of animals, especially mammalian organisms, to infectious agents and to malignancies.
Patent DE-69332330-T2 (DE)
Inventor: COUDENYS FRANS
IPC: H01S5/00
Filed: 1993-04-22
Granted: 2003-05-22
Abstract: PCT No. PCT/BE93/00019 Sec. 371 Date Apr. 11, 1994 Sec. 102(e) Date Apr. 11, 1994 PCT Filed Apr. 22, 1993 PCT Pub. No. WO93/22793 PCT Pub. Date Nov. 11, 1993.A method of fabricating a plurality of optoelectronic components on a semiconductor substrate, each optoelectronic component comprising several layers grown in a reactor. Every layer is being grown under a predetermined individual pressure. The active layers of all the components are lying substantially at the same height. Control of the pressure in the reactor during growth allows the thickness of the layer grown to be constant or to vary over the substrate area.